CXCL8 and breast cancer: In addition, there is a justified need for further research to more accurately determine the risk associated with the level of IL-6 and IL-8 expression and methylation for each stage of the disease, which will consequently make it possible to determine whether a pharmacological intervention aimed at modulating the level of IL-6 and IL-8 will have a therapeutic role in the treatment of BC.